Manjunath, M.; Ravindran, F.; Sharma, S.; Siddiqua, H.; Raghavan, S.C.; Choudhary, B.
Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes. Int. J. Mol. Sci. 2024, 25, 6485.
https://doi.org/10.3390/ijms25126485
AMA Style
Manjunath M, Ravindran F, Sharma S, Siddiqua H, Raghavan SC, Choudhary B.
Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes. International Journal of Molecular Sciences. 2024; 25(12):6485.
https://doi.org/10.3390/ijms25126485
Chicago/Turabian Style
Manjunath, Meghana, Febina Ravindran, Shivangi Sharma, Humaira Siddiqua, Sathees C. Raghavan, and Bibha Choudhary.
2024. "Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes" International Journal of Molecular Sciences 25, no. 12: 6485.
https://doi.org/10.3390/ijms25126485
APA Style
Manjunath, M., Ravindran, F., Sharma, S., Siddiqua, H., Raghavan, S. C., & Choudhary, B.
(2024). Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes. International Journal of Molecular Sciences, 25(12), 6485.
https://doi.org/10.3390/ijms25126485
